Journal
ACTA NEUROPATHOLOGICA
Volume 126, Issue 2, Pages 189-205Publisher
SPRINGER
DOI: 10.1007/s00401-013-1129-2
Keywords
Pyroglutamate Abeta; Toxicity; Neuron loss; Degeneration; Transgenic mouse model; Spatial reference memory
Categories
Ask authors/readers for more resources
N-truncated A beta(4-42) is highly abundant in Alzheimer disease (AD) brain and was the first A beta peptide discovered in AD plaques. However, a possible role in AD aetiology has largely been neglected. In the present report, we demonstrate that A beta(4-42) rapidly forms aggregates possessing a high aggregation propensity in terms of monomer consumption and oligomer formation. Short-term treatment of primary cortical neurons indicated that A beta(4-42) is as toxic as pyroglutamate A beta(3-42) and A beta(1-42). In line with these findings, treatment of wildtype mice using intraventricular A beta injection induced significant working memory deficits with A beta(4-42), pyroglutamate A beta(3-42) and A beta(1-42). Transgenic mice expressing A beta(4-42) (Tg4-42 transgenic line) developed a massive CA1 pyramidal neuron loss in the hippocampus. The hippocampus-specific expression of A beta(4-42) correlates well with age-dependent spatial reference memory deficits assessed by the Morris water maze test. Our findings indicate that N-truncated A beta(4-42) triggers acute and long-lasting behavioral deficits comparable to AD typical memory dysfunction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available